中西医基于肠肾轴对IgA肾病的认识和治疗
Treatment of IgA nephropathy based on the gut-kidney axis in traditional Chinese and Western medicine
- 现代中医临床 2022年29卷第2期 页码：72-76
- 作者机构：
1.陕西中医药大学 咸阳 712046
2.陕西中医药大学附属医院
- 作者简介：
高航，男，在读硕士生
# 刘春莹，女，主任医师，硕士生导师，E-mail：liuchy28@163.com
- 基金信息：陕西省科技厅自然科学基础研究计划项目(2017JM8134)
DOI：10.3969/j.issn.2095-6606.2022.02.017
中图分类号： R256.5纸质出版日期：2022-03-30，
收稿日期：2020-11-24，
- 稿件说明：
移动端阅览
高航, 赵亚洲, 刘春莹. 中西医基于肠肾轴对IgA肾病的认识和治疗[J]. 现代中医临床, 2022,29(2):72-76.
Hang GAO, Yazhou ZHAO, Chunying LIU. Treatment of IgA nephropathy based on the gut-kidney axis in traditional Chinese and Western medicine[J]. Modern Chinese Clinical Medicine, 2022,29(2):72-76.
高航, 赵亚洲, 刘春莹. 中西医基于肠肾轴对IgA肾病的认识和治疗[J]. 现代中医临床, 2022,29(2):72-76. DOI： 10.3969/j.issn.2095-6606.2022.02.017.
Hang GAO, Yazhou ZHAO, Chunying LIU. Treatment of IgA nephropathy based on the gut-kidney axis in traditional Chinese and Western medicine[J]. Modern Chinese Clinical Medicine, 2022,29(2):72-76. DOI： 10.3969/j.issn.2095-6606.2022.02.017.
摘要
IgA肾病是目前最常见的原发性肾小球疾病。近年来，肠道微生物群与IgA肾病(肠道－肾脏轴)之间的致病关联引起医学界的广泛关注。西医认为肠道微生物群是尿毒症毒素的一个潜在来源，肠道上皮屏障功能失调和肠道微生物群失调均会加速IgA肾病的进展。治疗上应调节肠道微生物群、应用新型治疗方法等。中医认为邪气侵袭与正气损伤是导致IgA肾病发生的两方面因素，并根据IgA肾病的病程特点将其分为急性发作期和慢性维持期，急性发作期，应通腑祛邪，慢性维持期，应顾护正气。
Abstract
IgA nephropathy is the most common primary glomerular disease. The pathogenic association between the gut microbiota and IgA nephropathy (gut-kidney axis) has attracted much medical attention in recent years. Western medicine considers the gut microbiota as a potential source of toxins in uremia
and both dysfunction of the intestinal epithelial barrier and dysbiosis of the gut microbiota accelerate the progression of IgA nephropathy. Accordingly
treatment should include regulation of the intestinal microbiota and application of new therapeutic methods. Traditional Chinese medicine believes that the attack of pathogenic qi and the damage of healthy qi are the two factors that lead to the development of IgA nephropathy
and according to the characteristics of the course of IgA nephropathy
it is divided into the acute attack phase and the chronic maintenance phase. During acute attacks
bowels are supposed to be unblocked to expel the pathogenic factors
while during chronic maintenance
the healthy Qi should be protected.
关键词
IgA肾病肠肾轴肠道微生物中医西医
Keywords
IgA nephropathygut-kidney axisgut microbestraditional Chinese medicineWestern medicine
references
LIANG H, DAI Z, LIU N, et al. Dietary l-tryptophan modulates the structural and functional composition of the intestinal microbiome in weaned piglets[J]. Frontiers in Microbiology, 2018, 9(3):1736-1745.
MACIEL R A, REMPEL L C, BOSQUETTI B, et al. P-cresol but not p-cresyl sulfate stimulate MCP-1 production via NF-κB p65 in human vascular smooth muscle cells[J]. J Bras Nefrol, 2016, 38(2):153-160.
ZEISEL S H, WARRIER M. Trimethylamine N-Oxide, the microbiome, and heart and kidney disease[J]. Annu Rev Nutr, 2017, 37(2):157-181.
MAIR R D, SIRICH T L, PLUMMER N S, et al. Characteristics of colon-derived uremic solutes[J]. Clin J Am Soc Nephrol, 2018, 13(9):1398-1404.
YACOUB R, WYATT C M.Manipulating the gut microbiome to decrease uremic toxins[J]. Kidney Int, 2017, 91(3):521-523.
KIEFFER D A, PICCOLO B D, VAZIRI N D, et al.Resistant starch alters gut microbiome and metabolomic profiles concurrent with amelioration of chronic kidney disease in rats[J]. Am J Physiol Renal Physiol, 2016, 310(9):857-871.
WU I W, GAO S S, CHOU H C, et al.Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease[J].Theranostics, 2020,10(12):5398-5411.
WANG Y F, ZHENG L J, LIU Y, et al.The gut microbiota-inflammation-brain axis in end-stage renal disease：perspectives from default mode network[J]. Theranostics, 2019, 9(26):8171-8181.
KAYAMA H, OKUMURA R, TAKEDA K. Interaction between the microbiota, epithelia, and immune cells in the intestine [J]. Annu Rev Immunol, 2020, 38(2):23-48.
KIRYLUK K, NOVAK J. The genetics and immunobiology of IgA nephropathy[J]. J Clin Invest, 2014, 124(6):2325-2332.
ZHAI Y L, ZHU L, SHI S F, et al.Increased april expression induces IgA1 aberrant glycosylation in IgA nephropathy[J]. Medicine, 2016, 95(11): 3099-3109.
EVENEPOEL P, POESEN R, MEIJERS B. The gut-kidney axis[J]. Pediatr Nephrol, 2017, 32(11):2005-2014.
MAHMOODPOOR F, RAHBAR SAADAT Y, BARZEGARI A, et al.The impact of gut microbiota on kidney function and pathogenesis[J]. Biomed Pharmacother, 2017, 93(3):412-419.
DE ANGELIS M, MONTEMURNO E, PICCOLO M, et al. Microbiota and metabolome associated with Immunoglobulin A Nephropathy (IgAN) [J]. PLoS One, 2014, 9(6): 990-1003.
BRITO J S, BORGES N A, DOLENGA C J, et al. Is there a relationship between tryptophan dietary intake and plasma levels of indoxyl sulfate in chronic kidney disease patients on hemodialysis? [J]. J Bras Nefrol, 2016, 38(4):396-402.
HAN L, FANG X, HE Y, et al. Isn forefronts symposium 2015：IgA nephropathy, the gut microbiota, and gut？kidney crosstalk [J]. Kidney International Reports, 2016, 1(3):189-196.
CHEMOUNY J M, GLEESON P J, ABBAD L, et al. Modulation of the microbiota by oral antibiotics treats immunoglobulin A nephropathy in humanized mice[J]. Nephrol Dial Transplant, 2019, 34(7):1135-1144.
JANA B, SALOMON D. Type Ⅵ secretion system: a modular toolkit for bacterial dominance[J]. Future Microbiol. 2019, 14(1):1451-1463.
SINGH N, GURAV A, SIVAPRAKASAM S, et al.Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis[J]. Immunity, 2014, 40(1):128-139.
FIORUCCI S, DISTRUTTI E. Bile acid-activated receptors，intestinal microbiota, and the treatment of metabolic disorders[J].Trends Mol Med, 2015,21(11):702-714.
JACOBSON A, LAM L, RAJENDRAM M, et al. A gut commensal-produced metabolite mediates colonization resistance to salmonella infection[J].Cell Host Microbe, 2018,24(2):296-307.
HUANG J, PEARSON J A, PENG J, et al.Gut microbial metabolites alter IgA immunity in type 1 diabetes[J]. JCI Insight, 2020, 5(10):e135718.
FRISBEE A L, PETRI W A, J R.Considering the immune system during fecal microbiota transplantation for clostridioides difficile infection [J]. Trends Mol Med, 2020, 26(5):496-507.
SANDERS M E, MERENSTEIN D J, REID G, et al. Probiotics and prebiotics in intestinal health and disease：from biology to the clinic[J].Nat Rev Gastroenterol Hepatol, 2019,16(10):605-616.
FLINT H J, DUNCAN S H, SCOTT K P, et al. Links between diet, gut microbiota composition and gut metabolism [J]. Proc Nutr Soc, 2015, 74(1):13-22.
SCHULMAN G, BERL T, BECK G J, et al.Randomized placebo-controlled EPPIC trials of ast-120 in CKD[J]. J Am Soc Nephrol, 2015, 26(7):1732-1746.
中国中西医结合学会肾脏疾病专业委员会.IgA肾病西医诊断和中医辨证分型实践指南[J].中国中西医结合杂志,2013,33(5):583-585.
高坤，夏平，易岚，等.基于数据挖掘的国医大师邹燕勤教授治疗IgA肾病的学术特色及用药规律分析[J].现代中医临床,2020,27(6):27-32.
白亚君，杜艳彬，袁心柱，等.大黄酚介导TLR4/NF-κB通路对IgA肾病大鼠肾损伤和免疫反应的调控作用[J].四川大学学报(医学版),2019,50(6):840-846.
LI C, ZHANG J, XU H, et al. Effect of dahuang danpi decoction on lactobacillus bulgaricus growth and metabolism: in vitro study[J]. Medicine, 2019, 98(5):139-141.
李君秋，肖铁刚，阙任烨，等.基于调节肠道菌群探讨大承气汤治疗急性胰腺炎的研究进展[J].中国中西医结合急救杂志,2019,26(6):758-761.
胡雄，孙晓铭.依替米星注射液合用大黄附子汤对急诊重症脓毒症患者胃肠功能障碍的影响[J].现代中西医结合杂志,2019,28(22):2453-2456.
吴有性.温疫论[M].张成博，李晓梅，唐迎雪，点校.天津：天津科学技术出版社，2003：96.
张琳.肠道微生态环境与儿童过敏性疾病的关系以及参芪健脾方对肠黏膜屏障功能修复和免疫功能调整的研究[D].石家庄：河北医科大学，2011.
涂轩，刘鹏，钟元涛，等.香砂六君子汤对肿瘤患者化疗期间食欲调节因子及肠道益生菌影响[J].临床军医杂志,2020,48(1):75-76.
黄文武，彭颖，王梦月，等.四君子汤及其单味药水煎液对脾虚大鼠肠道菌群的调节作用[J].中国实验方剂学杂志,2019,25(11):8-15.
辜沅，舒青龙.基于肠道微生态的参苓白术散药理研究进展[J].时珍国医国药,2018,29(3):674-676.
甘露.玉屏风散多糖对小鼠免疫功能的影响[J].免疫学杂志,2013,29(2):182-184.
0
浏览量
17
下载量
0
CSCD
- 网络PDF下载
- BibTeX下载
- Endnote下载
- RefMan 下载
- NoteExpress下载
- NoteFirst下载
关联资源
相关文章
相关作者
相关机构
- 技术支持由北京北大方正电子有限公司提供 京ICP备09064830号-19
京公网安备11010802024621 - 本系统建议在Chrome、 IE9+ 以上版本浏览器阅读本站内容，360浏览器请切换至极速模式
- Cookies帮助我们提供服务并提供个性化体验。使用本网站，即表示您同意我们使用Cookies